What is Insmed's retained earnings?

Insmed (INSM) reported retained earnings of -$5.8B in Q1 2026.

How has Insmed's retained earnings changed year-over-year?

Insmed's retained earnings decreased by 25.6% year-over-year, from -$4.62B to -$5.8B.

What is the long-term trend for Insmed's retained earnings?

Over 5 years (2020 to 2025), Insmed's retained earnings has grown at a 25.2% compound annual growth rate (CAGR), from -$1.83B to -$5.64B.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Insmed INSM Retained Earnings

Retained Earnings at other companies

Sarepta Therapeutics, Inc.SRPT

-$4.55B+2.4%

United TherapeuticsUTHR

$8.83B+17.1%

Solid Biosciences Inc.SLDB

-$1.01B-23.3%

ANI PharmaceuticalsANIP

$6.39M+108%

Regeneron PharmaceuticalsREGN

$36.42B+12.5%

SavaraSVRA

-$645.37M-25.1%

Other financials

Income statement

See full

Revenue$306.0M+230%

Gross profit$258.5M+261%

Operating income-$153.3M+38.2%

Net income-$163.6M+36.3%

EPS (diluted)-$0.76+46.5%

Balance sheet

See full

Cash & equivalents$582.2M+44.4%

Total debt$580.3M-49.2%

Total equity$704.9M+611%

Total assets$2.1B+15.2%

Cash flow

See full

Operating cash flow-$222.7M+15.0%

CapEx$3.5M-65.4%

Free cash flow-$226.2M+16.9%

Valuation

See full

Market cap$23.11B+17.6%

Enterprise value$23.11B+22.0%

P/S28.2×-21.1×

Profitability

See full

Gross margin81.8%+5.3pp

Operating margin-140.6%-43.9pp

Net margin-144.4%-45.3pp

FCF margin-112.5%-35.3pp

Returns & leverage

See full

Return on equity-294.5%—

Debt / equity0.8×-10.7×

Current ratio4.5×-1.4×

Where this comes from

Reported directly by Insmed in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insmed's retained earnings?: Insmed (INSM) reported retained earnings of -$5.8B in Q1 2026.
How has Insmed's retained earnings changed year-over-year?: Insmed's retained earnings decreased by 25.6% year-over-year, from -$4.62B to -$5.8B.
What is the long-term trend for Insmed's retained earnings?: Over 5 years (2020 to 2025), Insmed's retained earnings has grown at a 25.2% compound annual growth rate (CAGR), from -$1.83B to -$5.64B.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.